Kalfoutzou A, Restemi A, Rapti C, Chaleplidis N, Bagiokou E, Bartzi D
Cureus. 2024; 16(11):e73105.
PMID: 39650873
PMC: 11621874.
DOI: 10.7759/cureus.73105.
Yang J, Song X, Zhang H, Liu Q, Wei R, Guo L
Nat Cancer. 2024; 5(12):1919-1939.
PMID: 39543363
DOI: 10.1038/s43018-024-00855-5.
Li Y, Zhao X, Tao Y
World J Surg Oncol. 2024; 22(1):163.
PMID: 38909260
PMC: 11193278.
DOI: 10.1186/s12957-024-03448-9.
Alsarari A, Abdulkader A, Farooqi W, Al-Shibani S, Al Khuwaitir T
Cureus. 2024; 16(3):e56434.
PMID: 38638776
PMC: 11024664.
DOI: 10.7759/cureus.56434.
Kim K, Min H
Heliyon. 2023; 9(11):e22311.
PMID: 38053881
PMC: 10694305.
DOI: 10.1016/j.heliyon.2023.e22311.
Olfactory neuroblastoma: diagnosis, management, and current treatment options.
Tosoni A, Di Nunno V, Gatto L, Corradi G, Bartolini S, Ranieri L
Front Oncol. 2023; 13:1242453.
PMID: 37909011
PMC: 10613987.
DOI: 10.3389/fonc.2023.1242453.
Primary Sellar Neuroblastoma Masquerading as a Pituitary Macroadenoma.
Seshan N, Hanft S, Goswami G, Syal A
JCEM Case Rep. 2023; 1(4):luad081.
PMID: 37908997
PMC: 10580437.
DOI: 10.1210/jcemcr/luad081.
Olfactory Neuroblastoma-A Challenging Fine Line between Metastasis and Hematology.
Marina T, Constantin B, Flavia B, Silvana S, Marioara P, Sarau C
Medicina (Kaunas). 2023; 59(4).
PMID: 37109689
PMC: 10146428.
DOI: 10.3390/medicina59040731.
Case report: The treatment for olfactory neuroblastoma combined with leptomeningeal carcinomatosis an ommaya reservoir.
Peng Y, Kang X, Jiang B, Chen F, Yang S, Kang Z
Front Oncol. 2023; 12:1060575.
PMID: 36713576
PMC: 9880206.
DOI: 10.3389/fonc.2022.1060575.
Persistent pain and numbness in the extremities of an adult due to paraneoplastic peripheral neuropathy caused by olfactory neuroblastoma: A case report.
Liang W, Wang Y, Sun W, Li D, Zhang X, Zhu P
Front Neurol. 2023; 13:1002076.
PMID: 36698887
PMC: 9868692.
DOI: 10.3389/fneur.2022.1002076.
The role of ADC value and Ki-67 index in predicting the response to neoadjuvant chemotherapy in advanced stages of olfactory neuroblastoma.
Wang Y, Zhang S, Yu W, Wang Y, Yan F, Yang B
Br J Radiol. 2022; 95(1140):20220367.
PMID: 36240450
PMC: 9733604.
DOI: 10.1259/bjr.20220367.
[68Ga]-DOTATATE PET/CT and PET/MRI in the diagnosis and management of esthesioneuroblastoma: illustrative cases.
Roytman M, Tassler A, Kacker A, Schwartz T, Dobri G, Strauss S
J Neurosurg Case Lessons. 2022; 1(2):CASE2058.
PMID: 35854930
PMC: 9241319.
DOI: 10.3171/CASE2058.
Management of Esthesioneuroblastoma: A Retrospective Study of 6 Cases and Literature Review.
Alami Z, Farhane F, Bouziane A, Mhirech S, Amrani Joutei S, Hassani W
Case Rep Oncol. 2022; 15(1):176-186.
PMID: 35431860
PMC: 8958627.
DOI: 10.1159/000521736.
Olfactory neuroblastoma resection through endoscopic endonasal approach: A rare case report.
Pradana Y, Sutikno B
Ann Med Surg (Lond). 2022; 73:103242.
PMID: 35079375
PMC: 8767289.
DOI: 10.1016/j.amsu.2022.103242.
Olfactory Neuroblastoma Managed with Endoscopic Sinus Surgery.
Al-Osaimi S, Hameed A, Alsufyani A, Altwairqi R, Alotaibi A
J Pharm Bioallied Sci. 2022; 13(Suppl 2):S1728-S1732.
PMID: 35018064
PMC: 8686966.
DOI: 10.4103/jpbs.jpbs_62_21.
An olfactory neuroblastoma presenting as posterior reversible leukoencephalopathy syndrome.
Doyle J, Hashimie Y, Metting A
Proc (Bayl Univ Med Cent). 2021; 34(6):724-725.
PMID: 34733002
PMC: 8545063.
DOI: 10.1080/08998280.2021.1953878.
The Treatment Outcomes of Olfactory Neuroblastoma Patients With Frontal Lobe Invasion.
Wang J, Wang L, He H, Li Y, Song X
Front Oncol. 2021; 11:640892.
PMID: 34290975
PMC: 8289277.
DOI: 10.3389/fonc.2021.640892.
Synergistic Effect of Statins and Abiraterone Acetate on the Growth Inhibition of Neuroblastoma Targeting Androgen Receptor.
Hu Z, Cheng C, Wang Y, Chen T, Tu J, Niu C
Front Oncol. 2021; 11:595285.
PMID: 34041015
PMC: 8141582.
DOI: 10.3389/fonc.2021.595285.
Durable Major Response With Pazopanib in Recurrent, Heavily Pretreated Metastatic Esthesioneuroblastoma Harboring a Fumarate Hydratase Mutation.
Spengler M, Wheelden M, Mackley H, Drabick J
JCO Precis Oncol. 2021; 5.
PMID: 34036225
PMC: 8140788.
DOI: 10.1200/PO.20.00486.
[Clinical analysis of 31 cases of esthesioneuroblastoma].
He X, Wang Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021; 35(4):338-340.
PMID: 33794633
PMC: 10128433.
DOI: 10.13201/j.issn.2096-7993.2021.04.012.